Article
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).
Molecular psychiatry - 1 Feb 2014
Lencz T, Knowles E, Davies G, Guha S, Liewald D C, Starr J M, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse Pamela, Lundervold A, Steen V M, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson J G, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick K E, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard S L, Keller M C, Andreassen O A, Deary I J, Glahn D C, Malhotra A K
Abstract excerpt
It has long been recognized that generalized deficits in cognitive ability represent a core component of schizophrenia (SCZ), evident before full illness onset and independent of medication. The possibility of genetic overlap between risk for SCZ and cognitive phenotypes has been suggested by the presence of cognitive deficits in first-degree relatives of patients with SCZ; however, until recently, molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.